Rhabdomyosarcoma natural history, complications and prognosis

Revision as of 13:42, 10 September 2015 by Suveenkrishna Pothuru (talk | contribs)
Jump to navigation Jump to search

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma natural history, complications and prognosis

CDC on Rhabdomyosarcoma natural history, complications and prognosis

Rhabdomyosarcoma natural history, complications and prognosis in the news

Blogs on Rhabdomyosarcoma natural history, complications and prognosis

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Common complication of rhabdomyosarcoma include metastasis to lung, bone marrow, and bone. Rhabdomyosarcoma is associated with a 5 year survival rate of 72%. The presence of metastasis is associated with a particularly poor prognosis. The embryonal type rhabdomyosarcoma is associated with the most favorable prognosis. Orbital and genitourinary tract rhabdomyosarcomas have the most favorable prognosis.

Complications

  • Rhabdomyosarcoma may cause metastasis to other organs.
  • Lung is the most common location for metastatic disease.[1]
  • Other common sites of metastasis are bone marrow and bones.

Prognosis

  • Rhabdomyosarcoma is associated with a 5 year survival rate of 72%.
  • The presence of metastasis is associated with a particularly poor prognosis among patients with rhabdomyosarcoma. The 5 year event free survival rate is less than 30%.
  • Embryonal type rhabdomyosarcoma is associated with the most favorable prognosis.
  • Prognosis varies with location of tumor- orbital and genitourinary tract rhabdomyosarcomas have the most favorable prognosis.

References

  1. "Patterns of spread".

Template:WH Template:WS